Kyle Bass might be viewing himself as the Robin Hood of the modern world. His latest plan is to liberate monopolistic drug patents from the clutches of greedy pharmaceutical companies, lowering the price of the drugs and making money by betting that the stock of those companies would go lower in price. Kyle Bass’ economic predictions Speaking to told a small group in Oslo, Norway and first reported in Reuters, Kyle Bass said his plan is a rare example of hedge funds aligning themselves with the public good. “This is going to lower drug prices for Medicare and for everyone,”…
Kyle Bass Wants To Be Robin Hood of Drug Prices
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.